| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |